Armodafinil and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Armodafinil (armodafinil), especially for people who are female, 60+ old, also take Nuplazid, and have Parkinson's disease.

The study is created by eHealthMe based on reports of 4,002 people who have side effects when taking Armodafinil from the FDA, and is updated regularly.

What is Armodafinil?

Armodafinil has active ingredients of armodafinil. It is often used in narcolepsy. eHealthMe is studying from 4,137 Armodafinil users. Check the latest studies of Armodafinil.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

4,002 people reported to have side effects when taking Armodafinil.
Among them, 44 people (1.1%) died.

Among these 44 people:

What is the gender of people who died when taking Armodafinil? *

female: 70 %
male: 30 %

What is the age of people who died when taking Armodafinil? *

What are other drugs people take besides Armodafinil? *

What are other side effects people have before they died? *

Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 11.36%
Thrombocytopenia (decrease of platelets in blood): 5 people, 11.36%
Pleural Effusion (water on the lungs): 4 people, 9.09%
Fever: 4 people, 9.09%
Weakness: 3 people, 6.82%
Osteonecrosis Of Jaw (death of bone of jaw): 3 people, 6.82%
Pneumonia: 3 people, 6.82%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 3 people, 6.82%
Fatigue (feeling of tiredness): 3 people, 6.82%
Osteomyelitis (infection of bone): 3 people, 6.82%

What are the existing conditions these people have? *

Parkinson's Disease: 8 people, 18.18%
Breast Cancer: 3 people, 6.82%
Breast Cancer Recurrent: 2 people, 4.55%
Depression: 2 people, 4.55%
Joint Pain: 2 people, 4.55%
Breast Cancer Female: 2 people, 4.55%
Osteoporosis (bones weak and more likely to break): 2 people, 4.55%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 4.55%
Anaemia (lack of blood): 2 people, 4.55%
Sleep Disorder: 2 people, 4.55%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Armodafinil:

Armodafinil (4,137 reports)

Expand to all the drugs that have ingredients of armodafinil:

Death and drugs with ingredients of armodafinil (180 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Armodafinil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,107 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on armodafinil (the active ingredients of Armodafinil) and Armodafinil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.